1 Cardiovascular and metabolic diseases, including obesity, remain important areas of unmet medical need, and we plan to continue applying our global capabilities to advance a pipeline of investigational treatments that have the potential to fill critical gaps in patient care, including continued development of our oral GIPR antagonist candidate and other earlier obesity programs, Chris Boshoff, MD, PhD, chief scientific officer and president of Research and Development at Pfizer, said in a news release
Rheumatoid arthritis and depression
At Meeting Point Health, EBOO supports longevity, recovery, and optimal cellular health
In todays blog, well explore how these injections work, their benefits, and how often you should consider getting them
For alcohol withdrawal : 1-3 grams of acetyl-L-carnitine has been given by IV over 3-4 hours for 10 days
Iron/Ferritin: Essential for energy and cognitive function